Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maisonneuve

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Brain Research|May 29, 1995
Kappa opioid inhibition of morphine and cocaine self-administration in ratsS D Glick, I M Maisonneuve, J Raucci, et al.
Brain Research|August 1, 1998
Acute iboga alkaloid effects on extracellular serotonin (5-HT) levels in nucleus accumbens and striatum in ratsD Wei, I M Maisonneuve, M E Kuehne, et al.
European Journal of Pharmacology|May 3, 2005
Is antagonism of alpha3beta4 nicotinic receptors a strategy to reduce morphine dependence?Olga D Taraschenko, Vishal Panchal, Isabelle M Maisonneuve, et al.
Brain Research|March 25, 1996
Ibogaine-like effects of noribogaine in ratsS D Glick, S M Pearl, J Cai, et al.
European Journal of Pharmacology|November 18, 2005
Attenuation of morphine withdrawal signs by intracerebral administration of 18-methoxycoronaridineVishal Panchal, Olga D Taraschenko, Isabelle M Maisonneuve, et al.
Synapse (New York, N.Y.)|April 21, 2007
18-MC acts in the medial habenula and interpeduncular nucleus to attenuate dopamine sensitization to morphine in the nucleus accumbensOlga D Taraschenko, Joseph M Shulan, Isabelle M Maisonneuve, et al.
European Journal of Pharmacology|March 22, 2002
Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administrationStanley D Glick, Isabelle M Maisonneuve, Barbara A Kitchen, et al.
European Journal of Pharmacology|August 30, 2011
Brain regions mediating α3β4 nicotinic antagonist effects of 18-MC on nicotine self-administrationStanley D Glick, Elizabeth M Sell, Sarah E McCallum, et al.
Psychopharmacology|February 1, 1997
Ibogaine and the dopaminergic response to nicotineI M Maisonneuve, G L Mann, C R Deibel, et al.
Brain Research|March 23, 1992
Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in ratsI M Maisonneuve, K L Rossman, R W Keller, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Brain Research|May 29, 1995
Kappa opioid inhibition of morphine and cocaine self-administration in ratsS D Glick, I M Maisonneuve, J Raucci, et al.
Brain Research|August 1, 1998
Acute iboga alkaloid effects on extracellular serotonin (5-HT) levels in nucleus accumbens and striatum in ratsD Wei, I M Maisonneuve, M E Kuehne, et al.
European Journal of Pharmacology|May 3, 2005
Is antagonism of alpha3beta4 nicotinic receptors a strategy to reduce morphine dependence?Olga D Taraschenko, Vishal Panchal, Isabelle M Maisonneuve, et al.
Brain Research|March 25, 1996
Ibogaine-like effects of noribogaine in ratsS D Glick, S M Pearl, J Cai, et al.
European Journal of Pharmacology|November 18, 2005
Attenuation of morphine withdrawal signs by intracerebral administration of 18-methoxycoronaridineVishal Panchal, Olga D Taraschenko, Isabelle M Maisonneuve, et al.
Synapse (New York, N.Y.)|April 21, 2007
18-MC acts in the medial habenula and interpeduncular nucleus to attenuate dopamine sensitization to morphine in the nucleus accumbensOlga D Taraschenko, Joseph M Shulan, Isabelle M Maisonneuve, et al.
European Journal of Pharmacology|March 22, 2002
Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administrationStanley D Glick, Isabelle M Maisonneuve, Barbara A Kitchen, et al.
European Journal of Pharmacology|August 30, 2011
Brain regions mediating α3β4 nicotinic antagonist effects of 18-MC on nicotine self-administrationStanley D Glick, Elizabeth M Sell, Sarah E McCallum, et al.
Psychopharmacology|February 1, 1997
Ibogaine and the dopaminergic response to nicotineI M Maisonneuve, G L Mann, C R Deibel, et al.
Brain Research|March 23, 1992
Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in ratsI M Maisonneuve, K L Rossman, R W Keller, et al.
Pageof 9